However, periodic breaks may help maintain receptor sensitivity
Get customized peptide recommendations based on whether you're dealing with joint pain, muscle pain, nerve pain, or inflammatory pain
10.4158/EP15758.OR 9 GreenblattM
4,887 participants treated with tirzepatide and 2,328 control participants were analyzed and 142 participants had at least one MACE-4 event
The total human evidence base, as of this writing, consists of the following: 1) a Phase I safety trial of 42 healthy volunteers that was registered in 2015, canceled in 2016, and never published, 2) a retrospective case series of 12 patients with knee pain, no control group, and no validated outcome measure, and 3) a 2025 pilot safety study involving two healthy adults who received intravenous infusions at a single private clinic in Florida